Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Alexander Schmittel"'
Autor:
Sven Jungmann, Wolf-Dieter Ludwig, Nicolas Schönfeld, Torsten-Gerriet Blum, Claudia Großwendt, Christian Boch, Beate Rehbock, Sergej Griff, Alexander Schmittel, Torsten T. Bauer
Publikováno v:
Case Reports in Oncological Medicine, Vol 2017 (2017)
We present a 74-year-old male with nonspecific interstitial pneumonia (NSIP) during treatment with ibrutinib for mantle cell lymphoma. Previously, the patient had received six cycles of bendamustine and rituximab and six cycles of R-CHOP, followed by
Externí odkaz:
https://doaj.org/article/3b5e46c103ec4501b44cc774b4d80c54
First-line treatment of EGFR-mutated nonsmall cell lung cancer: critical review on study methodology
Publikováno v:
European Respiratory Review, Vol 23, Iss 131, Pp 92-105 (2014)
Recent advances in understanding the mechanisms of nonsmall cell lung cancer (NSCLC) has led to the development of targeted treatments, including the reversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors gefitinib and erlotini
Externí odkaz:
https://doaj.org/article/5f57d49eedc542a989bb66c4c051719f
Autor:
Matthias W. Beckmann, Frederik A. Stübs, Martin C. Koch, Peter Mallmann, Christian Dannecker, Anna Dietl, Anna Sevnina, Franziska Mergel, Laura Lotz, Carolin C. Hack, Anne Ehret, Daniel Gantert, Franca Martignoni, Jan-Philipp Cieslik, Jan Menke, Olaf Ortmann, Carmen Stromberger, Karin Oechsle, Beate Hornemann, Friederike Mumm, Christoph Grimm, Alina Sturdza, Edward Wight, Kristina Loessl, Michael Golatta, Volker Hagen, Timm Dauelsberg, Ingo Diel, Karsten Münstedt, Eberhard Merz, Dirk Vordermark, Katja Lindel, Christian Wittekind, Volkmar Küppers, Ralph Lellé, Klaus Neis, Henrik Griesser, Birgit Pöschel, Manfred Steiner, Ulrich Freitag, Tobias Gilster, Alexander Schmittel, Michael Friedrich, Heidemarie Haase, Marion Gebhardt, Ludwig Kiesel, Michael Reinhardt, Michael Kreißl, Marianne Kloke, Lars-Christian Horn, Regina Wiedemann, Simone Marnitz, Anne Letsch, Isabella Zraik, Bernhard Mangold, Jochen Möckel, Céline Alt, Pauline Wimberger, Peter Hillemanns, Kerstin Paradies, Alexander Mustea, Dominik Denschlag, Ulla Henscher, Reina Tholen, Simone Wesselmann, Tanja Fehm
Publikováno v:
Geburtshilfe Frauenheilkd
Aim This update of the interdisciplinary S3 guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL) was published in March 2021. This updated guideline was funded by German Cancer Aid (Deutsche Krebshilfe) a
Autor:
Nikolaj Frost, Julia Roeper, Janna-Lisa Velthaus, Matthias Raspe, Elisabeth Olive, Alexander Schmittel, Bernd Schmidt, David Wasilewski, Julia Onken, Heike Lüders, Martin Witzenrath, Carolin Senger, Dirk Böhmer, Sonja Loges, Frank Griesinger, Dominik P. Modest, Christian Grohé
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 170
Local ablative therapy (LAT) improves survival in oligometastatic lung cancer (OMD), but there is limited information on recurrence patterns, re-treatments and in particular the role of brain metastases during the course of disease. We therefore cond
Autor:
Nikolaj Frost, Alexander Schmittel, Torsten Blum, Daniel Misch, Christian Grohé, Bernd Schmidt, Norbert Suttorp, Jens Kollmeier, D Pultermann, Antje Tessmer, Christian Grah, Martin Witzenrath, M. de Wit
Publikováno v:
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V..
Autor:
Kurt Possinger, Anne C. Regierer, Jan Eucker, Annette Dieing, Bernd Flath, Gunnar Folprecht, Michael Geißler, Florian Heidel, Erhard Hiller, Andreas Hochhaus, Kai Hübel, Henning Jann, Christian Jehn, Ulrich Keilholz, Konrad Klinghammer, Wolfgang Knauf, Hans-Jochem Kolb, Hannes Kroenlein, Anne Sophie Kubasch, Diana Lüftner, Matthias Möhlig, Ralph Naumann, Helmut Oettle, null Oettle, null Mayer, Ulrich-Frank Pape, Uwe Platzbecker, Andreas Rank, Peter Reichardt, Oliver Rick, Damian Rieke, Hanno Riess, Markus Ruhnke, Markus Schaich, Andreas Schalhorn, Ann-Kristin Schmälter, Alexander Schmittel, Christian Scholz, Hubert Schrezenmeier, Carsten-Oliver Schulz, Dorothee Speiser, Bertram Wiedenmann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a363a5963d11193e7aab7cf9b01e06fc
https://doi.org/10.1016/b978-3-437-21215-4.00032-9
https://doi.org/10.1016/b978-3-437-21215-4.00032-9
Autor:
Kurt Possinger, Anne C. Regierer, Jan Eucker, Annette Dieing, Bernd Flath, Gunnar Folprecht, Michael Geißler, Florian Heidel, Erhard Hiller, Andreas Hochhaus, Kai Hübel, Henning Jann, Christian Jehn, Ulrich Keilholz, Konrad Klinghammer, Wolfgang Knauf, Hans-Jochem Kolb, Hannes Kroenlein, Anne Sophie Kubasch, Diana Lüftner, Matthias Möhlig, Ralph Naumann, Helmut Oettle, Ulrich-Frank Pape, Uwe Platzbecker, Andreas Rank, Peter Reichardt, Oliver Rick, Damian Rieke, Hanno Riess, Markus Ruhnke, Markus Schaich, Andreas Schalhorn, Ann-Kristin Schmälter, Alexander Schmittel, Christian Scholz, Hubert Schrezenmeier, Carsten-Oliver Schulz, Dorothee Speiser, Bertram Wiedenmann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab3c431db9d814daa8f30afe7f8bec7f
https://doi.org/10.1016/b978-3-437-21215-4.00020-2
https://doi.org/10.1016/b978-3-437-21215-4.00020-2
Autor:
V. Kümmerlen, P. Mehlitz, L. Rohde, N. Utku, M. Knoedler, M. Machacek, M. Lassus, P. Treasure, Glyn B. Steventon, Konrad Klinghammer, Alexander Schmittel, U. Keilholz
Publikováno v:
European Journal of Cancer. 80:14-25
Aim An open-label, phase I dose-escalation trial was performed in adult patients with various solid cancers to identify the maximum tolerated dose (MTD), to assess the safety, pharmacokinetic profile and anti-tumour activity of the new prodrug CAP7.1
Autor:
Markus Moehler, Michael Neise, Holger Hebart, Marcus-Alexander Wörns, Jochen Rudi, Jan Wierecky, Claudia Lang, Martin Indorf, Peter R. Galle, Klaus Maria Josten, Emil Boller, Frank Staib, Michael Heike, Peter Ehscheidt, Alexander Schmittel, Carl C. Schimanski, T. Göhler, Gerrit Dingeldein, Thomas Geer, Thomas Flohr, Meinolf Karthaus
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 143:1023-1034
Cetuximab-induced skin rash Gd3+ occurs in ≥16% patients (pts) (Heinemann et al., Lancet Oncol 15(10):1065–1075, 2014; Van Cutsem et al. J Clin Oncol 27(19):3117–25; 2009b). Survival, response, and toxicity parameters were re-evaluated under a
Autor:
Nicolas Schönfeld, Sven Jungmann, Beate Rehbock, Wolf-Dieter Ludwig, Torsten-Gerriet Blum, Torsten T. Bauer, C Großwendt, Christian Boch, Sergej Griff, Alexander Schmittel
Publikováno v:
Case Reports in Oncological Medicine, Vol 2017 (2017)
Case Reports in Oncological Medicine
Case Reports in Oncological Medicine
We present a 74-year-old male with nonspecific interstitial pneumonia (NSIP) during treatment with ibrutinib for mantle cell lymphoma. Previously, the patient had received six cycles of bendamustine and rituximab and six cycles of R-CHOP, followed by